(CIDRAP News) An analysis of 2009 H1N1 influenza virus isolates from the 2010-11 flu season suggests that low-level community transmission of an oseltamivir-resistant strain took place, a development that bears close watching, researchers reported today.
(CIDRAP News) The United Kingdom today released an update of its flu pandemic plan, which for the first time addresses three varying levels of impact.
The revision updates the region's 2007 plan, and many of the changes revolve around lessons learned during the 2009 H1N1 pandemic and the latest scientific evidence, the Department of Health said in a press release.
(CIDRAP News) Australian public health officials yesterday reported a cluster of oseltamivir (Tamiflu)-resistant 2009 H1N1 infections, one of the largest to date, centered in one region of New South Wales state.
(CIDRAP News) Researchers who combed through scores of serologic studies estimate that the global cumulative incidence of pandemic H1N1 influenza infection before vaccines became available was probably below 20%, far lower than the 50% that pandemic planners had envisioned as a possible worst case.
(CIDRAP News) – A five-country study from Europe indicates that the use of adjuvanted vaccines against the pandemic H1N1 influenza virus probably did not increase the risk of Guillain-Barre syndrome (GBS), but the investigators could not firmly rule out a slightly greater chance of suffering the paralytic condition.